Pharmaceutical Executive June 12, 2024
Mike Hollan

Hypermedica and Ro announced platforms to help patients find access to affordable weight loss medications.

Virtual care and telehealth company Hypermedica announced that is has formed partnerships with various pharmacies from around the U.S. to address shortages and rising costs of GLP-1 medications.1 These medications are popular weight loss treatments and have seen demand skyrocket in the past two years. According to Hypermedica, its goal is to ensure that patients have access to these medications without having to utilize unreputable sources.

Hypermedica plans to use its digital platform to connect patients with services like real-time consultations, monitoring, and treatments and allow more patients to find sources of GLP-1 medications without being limited to their geographical location. The company is offering...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Pharma, Pharma / Biotech, Technology, Telehealth
Hospital recovery at risk if Congress doesn’t extend telehealth, Fitch Ratings says
Election Implications for Telehealth, Health Equity, AI and Life Sciences
Telehealth Advocates Praise DEA’s 3rd Extension of Telemedicine Flexibilities, but Call for Further Action
Trending in Telehealth: October 29 - November 11, 2024
How we can safeguard patients without restricting telehealth access

Share This Article